ESSA Pharma Inc.
ESSA Pharma Inc. (EPIX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · EPIX · as of Sep 30, 2025
Ownership Breakdown
39
Institutional Holders
▼ 4 vs Q2
$4.30M
Total Inst. Value
▼ $48.95M vs Q2
47.31M
Shares Outstanding
freeFloat 94.01%
22.52M
13F Shares Held
▼ 8.45M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
EPIX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BVF INC/IL pharmaceutical preparations | 11.67M | 26.29% | 26.29% | $2.23B | Nov 14, 2025 | ▲ 2.92M |
SOLEUS CAPITAL MANAGEMENT, L.P. pharmaceutical preparations | 4.36M | 9.83% | 9.83% | $833.15M | Nov 14, 2025 | ▲ 2.10M |
MORGAN STANLEY pharmaceutical preparations | 1.90M | 4.29% | 4.29% | $363.68M | May 27, 2026 | ▼ 2.31M |
PFIZER INC pharmaceutical preparations | 1.68M | 3.77% | 3.77% | $319.93M | Nov 13, 2025 | — held |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 591.8K | 1.33% | 1.33% | $113.04M | Feb 3, 2026 | ▼ 36.1K |
LMR PARTNERS LLP pharmaceutical preparations | 541.0K | 1.22% | 1.22% | $103.33M | Nov 14, 2025 | ▲ 341.0K |
SHAY CAPITAL LLC pharmaceutical preparations | 536.5K | 1.21% | 1.21% | $102.48M | Nov 14, 2025 | ▲ 512.2K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 384.2K | 86.55% | 86.55% | $73.00M | Nov 14, 2025 | ▲ 8.1K |
TWO SIGMA INVESTMENTS, LP pharmaceutical preparations | 336.2K | 75.73% | 75.73% | $64.21M | Nov 14, 2025 | ▲ 113.8K |
TWO SIGMA ADVISERS, LP pharmaceutical preparations | 214.8K | 48.39% | 48.39% | $41.03M | Nov 14, 2025 | ▼ 46.0K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
10
Increased
+6.13M shares10
New Positions
first time holders11
Decreased
−2.92M shares11
Sold Out
fully exitedNet shares change (top 50)
+3.21M
+6.13M / −2.92M
Net new holders
-2
10 new / 11 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
EPIX insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
4
Sell transactions
0.75
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Parkinson David Ross President and CEO | Oct 9, 2025 | D-Return | 65,675 | $0.12 | $7.9K | 0 | Form 4 ↗ |
Wood David S. Chief Financial Officer | Oct 9, 2025 | D-Return | 33,343 | $0.12 | $4.0K | 0 | Form 4 ↗ |
BERGER FRANKLIN M director | Oct 9, 2025 | D-Return | 784,404 | $0.12 | $94.1K | 0 | Form 4 ↗ |
Glickman Richard M director | Oct 9, 2025 | D-Return | 43,240 | $0.12 | $5.2K | 0 | Form 4 ↗ |
Requadt Scott director | Oct 9, 2025 | D-Return | 30,002 | $0.12 | $3.6K | 0 | Form 4 ↗ |
Martin John Alexander director | Oct 9, 2025 | D-Return | 14,299 | $0.12 | $1.7K | 0 | Form 4 ↗ |
Thorell Marella director | Oct 9, 2025 | D-Return | 2,881 | $0.12 | $345.72 | 0 | Form 4 ↗ |
BVF PARTNERS L P/IL 10 percent owner | Oct 9, 2025 | U-Tender | 560,797 | $0.12 | $69.7K | 0 | Form 4 ↗ |
BVF PARTNERS L P/IL 10 percent owner | Aug 5, 2025 | X-InTheMoney | 1,481,634 | $0.00 | $148.163 | 6.19M | Form 4 ↗ |
BVF PARTNERS L P/IL 10 percent owner | Aug 5, 2025 | Sale | 79 | $1.88 | $148.354 | 6.19M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
ESSA Pharma Inc. (EPIX) is primarily owned by institutional investors, who hold approximately 47.6% of total shares outstanding. Company insiders own approximately 5.99%, while retail and public investors account for the remaining 46.41%.
The largest institutional shareholder of ESSA Pharma Inc. is BVF INC/IL, holding approximately 11.67 million shares — equal to 26.29% of outstanding shares — as of September 30, 2025.
A total of 39 institutional investors currently hold EPIX stock, with a combined institutional value of approximately $4,301,584 as of the most recent 13F filing period.
Frequently asked questions
EPIX ownershipESSA Pharma Inc. (EPIX) is primarily owned by institutional investors, who hold approximately 47.6% of shares. The largest shareholder is BVF INC/IL with a 26.29% stake. Company insiders hold 5.99%. Data sourced from SEC Form 13F as of September 30, 2025.